Erin Hertlein, PhD

Erin Hertlein


College of Medicine


Internal Medicine

Academic Title

Res Asst Professor

Research Program

Leukemia Research

Research Interest

Leukemia, Lymphocytic, Chronic, B-Cell ● Cancer ● Leukemia ● Lymphoma ● Lymphoma, Mantle-Cell ● Leukemia, B-Cell ● Leukemia, Hairy Cell

Erin Hertlein, PhD, is a member of the Leukemia Research Program at the OSUCCC – James. Her research centers on NF-KB and other cancer-relevant cell signaling pathways.

Dr. Hertlein is researching novel therapies that target Hsp90, EZH2, IDH proteins and other epigenetic pathways in lymphoid and myeloid diseases. She also studies the therapeutic mechanisms of these agents, including combination therapy and clinical application.

Dr. Hertlein has co-authored several articles appearing in well-respected publications, such as Clinical Cancer Research, Blood and Journal of Biological Chemistry. She also has presented her research to a number of conferences, including the International Workshop on Chronic Lymphocytic Leukemia, CLL Research Consortium and American Society of Hematology.

Office Location

481-C OSUCCC Building

410 W 12th Ave, Columbus, OH 43210



Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication